Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Enigma Diagnostics and GSK Announce Collaboration on Assay Development and Commercialization of Enigma’s ML Platform

August 10, 2011 By Bio-Medicine.Org

LONDON and OXFORD, England, Aug. 10, 2011 /PRNewswire/ — Enigma
Diagnostics Limited (Enigma) and GlaxoSmithKline (GSK) today
announced that they have signed agreements for the supply and
commercialization on an exclusive basis of the Enigma® ML
system in Europe and other designated key countries, including
India, Brazil and Russia. The agreements include development by
Enigma of an initial range of respiratory tests for use on its
real-time Polymerase Chain Reaction (PCR) technology platform, and
provide GSK the opportunity to generate revenues from further test
developments in infectious diseases and in other therapeutic areas
relevant to its healthcare business.  

The Enigma® ML system has the potential to deliver a result
from a raw sample in under 60 minutes in a point of need setting.
The new collaboration significantly extends the scope of the
Influenza partnership announced in July 2009 for the Enigma® ML
system and builds on GSK’s extensive expertise and heritage within
the respiratory therapeutic area and the extended capabilities
offered by the Enigma® ML system.  

Under the terms of this agreement, GSK will make an additional
equity investment and upfront payment, R&D-related payments,
and royalties on net sales of resulting products. Additional
payments will be subject to agreed commercialization
milestones.

John McKinley, Chairman and CEO of Enigma, said: “This is a
major collaboration and represents a significant milestone for
Enigma. These agreements for assay development, commercialization
and supply will leverage GSK’s extensive sales and marketing force
with Enigma’s unique Point of Care system which has potential uses
across a number of human diseases. This is a partnership which will
deliver much needed “test and treat” capability to infectious
disease management.”

Eddie Gray, President, Pharmaceuticals Europe of GSK said: “GSK
is committed to improving the lives of patients suffer

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech